Since EBP50 depletion in outer tumor regions was significantly associated with several unfavorable prognostic factors in our CRC series, we surmise that a region-specific analysis of EBP50 expression may be required if this protein is to be used as a prognostic marker in CRC. The gene discussed is NHERF1; the disease is neoplasm.